//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: isPartOf:"Symposium on the US brand name prescription drug antitrust litigation"
Narrow search
Narrow search
Year of publication
From:
To:
Subject
All
Pharmaceutical distributors
7
Pharmahandel
7
Theorie
7
Theory
7
USA
7
United States
7
Competition policy
6
Pharmaceutical industry
6
Pharmaindustrie
6
Preisdifferenzierung
6
Price discrimination
6
Wettbewerbspolitik
6
Arzneimittel
1
Brand
1
Brand management
1
EU countries
1
EU-Staaten
1
Großbritannien
1
Markenartikel
1
Markenführung
1
Pharmaceuticals
1
Ramsey pricing
1
Ramsey-Preis
1
Restraints of competition
1
South Africa
1
Südafrika
1
United Kingdom
1
Welfare analysis
1
Wettbewerbsbeschränkung
1
Wohlfahrtsanalyse
1
more ...
less ...
Type of publication
All
Article
8
Type of publication (narrower categories)
All
Article in journal
5
Aufsatz in Zeitschrift
5
Language
All
English
8
Author
All
Culbertson, John
1
Danzon, Patricia Munch
1
Elzinga, Kenneth G.
1
Harrison, Jeffrey L.
1
Mills, David E.
1
Reekie, W. Duncan
1
Scherer, Frederic M.
1
Weinstein, Roy
1
Zaretsky, Henry W.
1
Zweifel, Peter
1
more ...
less ...
Published in...
All
International journal of the economics of business
8
Symposium on the US brand name prescription drug antitrust litigation
8
Source
All
ECONIS (ZBW)
8
Showing
1
-
8
of
8
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Price discrimination for pharmaceuticals : welfare effects in the US and the EU
Danzon, Patricia Munch
- In:
International journal of the economics of business
4
(
1997
)
3
,
pp. 301-321
Persistent link: https://www.econbiz.de/10001336957
Saved in:
2
The distribution and pricing of prescription drugs
Elzinga, Kenneth G.
- In:
International journal of the economics of business
4
(
1997
)
3
,
pp. 297-299
Persistent link: https://www.econbiz.de/10001336958
Saved in:
3
Cartels, spontaneous price discrimination and international pharmacy retailing
Reekie, W. Duncan
- In:
International journal of the economics of business
4
(
1997
)
3
,
pp. 279-285
Persistent link: https://www.econbiz.de/10001336960
Saved in:
4
Comment on: F. M. Scherer, "How US antitrust can go astray: the brand name prescription drug litigation"
Zweifel, Peter
- In:
International journal of the economics of business
4
(
1997
)
3
,
pp. 277-278
Persistent link: https://www.econbiz.de/10001336961
Saved in:
5
Comment on: F. M. Scherer, "How US antitrust can go astray: the brand name prescription drug litigation"
Zaretsky, Henry W.
- In:
International journal of the economics of business
4
(
1997
)
3
,
pp. 271-275
Persistent link: https://www.econbiz.de/10001336964
Saved in:
6
The brand name prescription drug litigation : comments on Scherer
Harrison, Jeffrey L.
- In:
International journal of the economics of business
4
(
1997
)
3
,
pp. 265-269
Persistent link: https://www.econbiz.de/10001336966
Saved in:
7
How US antitrust can be on target : the brand-name pescription drug litigation
Weinstein, Roy
- In:
International journal of the economics of business
4
(
1997
)
3
,
pp. 257-264
Persistent link: https://www.econbiz.de/10001336967
Saved in:
8
How US antitrust can go astray : the brand name pescription drug litigation
Scherer, Frederic M.
- In:
International journal of the economics of business
4
(
1997
)
3
,
pp. 239-256
Persistent link: https://www.econbiz.de/10001336969
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->